Atadja; Peter Wisdom

Patent Applications and Registrations

Patent applications and USPTO patent grants for Atadja; Peter Wisdom.The latest application filed is for "combination of lbh589 with other therapeutic agents for treating cancer".

Company Profile

0.1.30

Atadja; Peter Wisdom - Acton MA
Atadja; Peter Wisdom - Action MA
Atadja; Peter Wisdom - Parsippany NJ
Atadja, Peter Wisdom. - Parsippany NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination Of Lbh589 With Other Therapeutic Agents For Treating Cancer App 20180289670 - Atadja; Peter Wisdom ; et al.	2018-10-11
Combination Of Lbh589 With Other Therapeutic Agents For Treating Cancer App 20180071251 - Atadja; Peter Wisdom ; et al.	2018-03-15
Combination Of Lbh589 With Other Therapeutic Agents For Treating Cancer App 20170246147 - Atadja; Peter Wisdom ; et al.	2017-08-31
Combinations Of Therapeutic Agents For Treating Cancer App 20170027909 - Atadja; Peter Wisdom ; et al.	2017-02-02
Combination Of Hdac Inhibitors With Thrombocytopenia Drugs App 20160199350 - Atadja; Peter Wisdom ; et al.	2016-07-14
Combination Of Lbh589 With Other Therapeutic Agents For Treating Cancer App 20150094274 - Atadja; Peter Wisdom ; et al.	2015-04-02
Combination Of Hdac Inhibitors With Thrombocytopenia Drugs App 20130171141 - Atadja; Peter Wisdom ; et al.	2013-07-04
Combination Of Lbh589 With Other Therapeutic Agents For Treating Cancer App 20130029927 - Atadja; Peter Wisdom ; et al.	2013-01-31
Use Of Hdac Inhibitors For The Treatment Of Bone Destruction App 20120029047 - Atadja; Peter Wisdom ; et al.	2012-02-02
Combination of an HDAC inhibitor and an antimetabolite Grant 8,093,220 - Atadja January 10, 2	2012-01-10
Use Of Hdac Inhibitors For The Treatment Of Melanoma App 20110288144 - Atadja; Peter Wisdom	2011-11-24
Use Of Hdac Inhibitors For The Treatment Of Lymphomas App 20110124701 - Atadja; Peter Wisdom ; et al.	2011-05-26
Use Of Hdac Inhibitors For The Treatment Of Hodgkin's Disease App 20110118309 - Atadja; Peter Wisdom	2011-05-19
Use Of Hdac Inhibitors For The Treatment Of Melanoma App 20110034531 - Atadja; Peter Wisdom	2011-02-10
Use of HDAC Inhibitors for the Treatment of Bone Destruction App 20100179208 - Atadja; Peter Wisdom ; et al.	2010-07-15
Use Of Hdac Inhibitors For The Treatment Of Gastrointestinal Cancers App 20100137398 - Atadja; Peter Wisdom	2010-06-03
Combination Of An Hdac Inhibitor And An Antimetabolite App 20100069318 - Atadja; Peter Wisdom	2010-03-18
Combination Of Lbh589 With Other Therapeutic Agents For Treating Cancer App 20100069458 - Atadja; Peter Wisdom ; et al.	2010-03-18
Use Of Hdac Inhibitors For The Treatment Of Lymphomas App 20090281159 - Atadja; Peter Wisdom ; et al.	2009-11-12
Combination of Organic Compounds App 20080200489 - Atadja; Peter Wisdom ; et al.	2008-08-21
Combination of a Histone Deacetylase Inhibitor with a Death Receptor Ligand App 20070258972 - Atadja; Peter Wisdom ; et al.	2007-11-08
Combinations comprising staurosporines App 20070191338 - Atadja; Peter Wisdom ; et al.	2007-08-16
Epothilone resistant cell lines App 20070134744 - Atadja; Peter Wisdom ; et al.	2007-06-14
Combination of histone deacetylase inhibitors with chemotherapeutic agents App 20070123580 - Atadja; Peter Wisdom ; et al.	2007-05-31
Use of alpha-tubulin acetylation levels as a biomarker for protein deacetylase inhibitors App 20050227300 - Atadja, Peter Wisdom ; et al.	2005-10-13
Method for screening for compounds having hdac inhibitory activity App 20050118596 - Asselbergs, Fredericus Alphonsus Maria ; et al.	2005-06-02
Epothilone resistant cell lines App 20040038324 - Atadja, Peter Wisdom. ; et al.	2004-02-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.